From Wikipedia, the free encyclopedia
Jump to: navigation, search
Systematic (IUPAC) name
CAS Number 928822-98-4 N
PubChem CID: 50878551
ChemSpider 21106245 YesY
Chemical data
Formula C17H22N2O
Molecular mass 270.375 g/mol
 N (what is this?)  (verify)

5-MeO-DALT or N,N-diallyl-5-methoxytryptamine is a psychedelic tryptamine first synthesized by Alexander Shulgin.


The full name of the chemical is N-allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine. It is related to the compounds 5-MeO-DPT and DALT. Its metabolism has been described in scientific literature.[1]


The first material regarding the synthesis and effects of 5-MeO-DALT was sent from Alexander Shulgin to a research associate named Murple in May 2004, after which it was circulated online. In June 2004 5-MeO-DALT became available from internet research chemical vendors after being synthesized by commercial laboratories in China. In August 2004 the synthesis and effects of 5-MeO-DALT were published by Erowid.[2]


Doses ranging from 12–20 mg were tested by Alexander Shulgin's research group.[3]


There are numerous anecdotal reports of users consuming dosages far in excess of those tested by Alexander Shulgin,[citation needed] although there is no published literature on the toxicity of 5-MeO-DALT.

Legal Status[edit]


As of October 2015 5-MeO-DALT is a controlled substance in China.[4]


5-MeO-DALT became a controlled substance in Japan from April 2007, by amendment to the Pharmaceutical Affairs Law.[5]

United Kingdom[edit]

5-MeO-DALT became a Class A drug in the UK on January 7th 2015 after an update to the tryptamine blanket ban.


5-MeO-DALT is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[6]


Sveriges riksdag added 5-MeO-DALT to schedule I ("substances, plant materials and fungi which normally do not have medical use") as narcotics in Sweden as of May 1, 2012, published by Medical Products Agency in their regulation LVFS 2012:6 listed as 5-MeO-DALT N-allyl-N-[2-(5-metoxi-1H-indol-3-yl)etyl]-prop-2-en-1-amin.[7]

United States[edit]

5-MeO-DALT is not scheduled at the federal level in the United States,[8] but it is likely that it could be considered an analog of 5-Meo-DiPT or another tryptamine, in which case purchase, sale, or possession could be prosecuted under the Federal Analog Act.


5-MeO-DALT is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida.[9]


5-MeO-DALT is a Schedule I controlled substance in the state of Louisiana making it illegal to buy, sell, or possess in Louisiana.[10]


  1. ^ Julian A. Michely, Andreas G. Helfer, Simon D. Brandt, Markus R. Meyer, Hans H. Maurer (August 2015). "Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC–MS, LC–MS n , and LC–HR–MS–MS". Analytical and Bioanalytical Chemistry. doi:10.1007/s00216-015-8955-0. PMID 26297461. 
  2. ^ Hamilton Morris, Ash Smith (2 May 2010). "The Last Interview With Alexander Shulgin". Vice. Retrieved 3 September 2015. 
  3. ^ "Sasha Shulgin - 5-MeO-DALT, 2C-B-FLY & 5-EtOs". Retrieved 3 September 2015. 
  4. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015. 
  5. ^ "厚生労働省:平成18年度無承認無許可医薬品等買上調査の結果について" (in Japanese). Retrieved 24 July 2015. 
  6. ^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 24 July 2015. 
  7. ^ Generaldirektör Christina Rångemark Åkerman (20 April 2012). "Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika" (PDF) (in Swedish). Retrieved 3 September 2015. 
  8. ^ §1308.11 Schedule I.
  9. ^ Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL
  10. ^ "Louisiana State Legislature". Retrieved 3 September 2015. 

External links[edit]